| When worlds collide: Th17 and Treg cells in cancer and autoimmunity HM Knochelmann, CJ Dwyer, SR Bailey, SM Amaya, DM Elston, ... Cellular & molecular immunology 15 (5), 458-469, 2018 | 497 | 2018 |
| CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity BD Choi, X Yu, AP Castano, AA Bouffard, A Schmidts, RC Larson, ... Nature biotechnology 37 (9), 1049-1058, 2019 | 496 | 2019 |
| Th17 cells in cancer: the ultimate identity crisis SR Bailey, MH Nelson, RA Himes, Z Li, S Mehrotra, CM Paulos Frontiers in immunology 5, 276, 2014 | 431 | 2014 |
| CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma BD Choi, X Yu, AP Castano, H Darr, DB Henderson, AA Bouffard, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 289 | 2019 |
| CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours RC Larson, MC Kann, SR Bailey, NJ Haradhvala, PM Llopis, AA Bouffard, ... Nature 604 (7906), 563-570, 2022 | 269 | 2022 |
| Gene editing for immune cell therapies SR Bailey, MV Maus Nature biotechnology 37 (12), 1425-1434, 2019 | 212 | 2019 |
| Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence SR Bailey, MH Nelson, K Majchrzak, JS Bowers, MM Wyatt, AS Smith, ... Nature communications 8 (1), 1961, 2017 | 96 | 2017 |
| Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia MB Leick, H Silva, I Scarfò, R Larson, BD Choi, AA Bouffard, K Gallagher, ... Cancer cell 40 (5), 494-508. e5, 2022 | 95 | 2022 |
| Blockade or deletion of IFNγ reduces macrophage activation without compromising CAR T-cell function in hematologic malignancies SR Bailey, S Vatsa, RC Larson, AA Bouffard, I Scarfò, MC Kann, ... Blood Cancer Discovery 3 (2), 136-153, 2022 | 93 | 2022 |
| PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells JS Bowers, K Majchrzak, MH Nelson, BA Aksoy, MM Wyatt, AS Smith, ... Frontiers in immunology 8, 1221, 2017 | 87 | 2017 |
| Chimeric antigen receptor T cells targeting CD79b show efficacy in lymphoma with or without cotargeting CD19 M Ormhøj, I Scarfò, ML Cabral, SR Bailey, SJ Lorrey, AA Bouffard, ... Clinical Cancer Research 25 (23), 7046-7057, 2019 | 80 | 2019 |
| Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion JS Bowers, MH Nelson, K Majchrzak, SR Bailey, B Rohrer, ADM Kaiser, ... JCI insight 2 (5), 2017 | 76 | 2017 |
| The basics of artificial antigen presenting cells in T cell-based cancer immunotherapies LR Neal, SR Bailey, MM Wyatt, JS Bowers, K Majchrzak, MH Nelson, ... Journal of immunology research and therapy 2 (1), 68, 2017 | 75 | 2017 |
| Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors S Chatterjee, K Thyagarajan, P Kesarwani, JH Song, M Soloshchenko, ... Cancer research 74 (21), 6048-6059, 2014 | 66 | 2014 |
| Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic K Majchrzak, MH Nelson, SR Bailey, JS Bowers, XZ Yu, MP Rubinstein, ... Cancer Immunology, Immunotherapy 65, 247-259, 2016 | 50 | 2016 |
| β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity K Majchrzak, MH Nelson, JS Bowers, SR Bailey, MM Wyatt, JM Wrangle, ... JCI insight 2 (8), 2017 | 47 | 2017 |
| Dendritic cells in irradiated mice trigger the functional plasticity and antitumor activity of adoptively transferred Tc17 cells via IL12 signaling JS Bowers, MH Nelson, S Kundimi, SR Bailey, LW Huff, KM Schwartz, ... Clinical Cancer Research 21 (11), 2546-2557, 2015 | 40 | 2015 |
| Identification of human CD4+ T cell populations with distinct antitumor activity MH Nelson, HM Knochelmann, SR Bailey, LW Huff, JS Bowers, ... Science advances 6 (27), eaba7443, 2020 | 39 | 2020 |
| Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma A Schmidts, AA Srivastava, R Ramapriyan, SR Bailey, AA Bouffard, ... Neuro-Oncology Advances 5 (1), vdac185, 2023 | 35 | 2023 |
| Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning MH Nelson, JS Bowers, SR Bailey, MA Diven, CW Fugle, ADM Kaiser, ... Journal for immunotherapy of cancer 4, 1-14, 2016 | 31 | 2016 |
